Good presentation - a good introduction to the business for the newer investors who've come on-board and for those of us here a bit longer, a really solid and tight explanation of just where we are at!
I've been genuinely impressed with just how professional the business has been these last few weeks. It's important we continue to take the rest of this year to:
i) continue to drive forward Travelan at every opportunity [including US Defence partnerships] - we must give this a real priority, it's a money making product in the market and has billion dollar potential - travellers health is a BIG Money space and travellers’ diarrhoea is no laughing matter - Travelan's further success, will also have a big impact on how people look at and value our broader company!
ii) bed down where we're at [with NASH] and begin sounding out truly First Class potential partners in a future PhIII program,
iii) continue to progress our other clinical programs.
If we can spend the next 12-18months doing this, we'll be a transformed and much more valuable entity.
Add to My Watchlist
What is My Watchlist?
